India, April 25 -- IDEAYA Biosciences, Inc. (IDYA), a company focused on precision medicine in oncology, Friday announced the grant of non-qualified stock options to four newly hired employees on April 24, 2025.
The Compensation Committee of the company's Board of Directors granted a total of 185,400 stock options under the 2023 Employment Inducement Incentive Award Plan (2023 Inducement Plan), which is designed to incentivize new hires in accordance with Nasdaq Listing Rule 5635(c)(4).
The 2023 Inducement Plan exclusively provides equity awards to individuals who are not current employees of IDEAYA or those returning after a non-employment period, as an inducement for joining the company. The stock options granted have an exercise price ...